Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$649M |
| 2 |
Nike
NKE
|
+$453M |
| 3 |
Tesla
TSLA
|
+$431M |
| 4 |
AstraZeneca
AZN
|
+$389M |
| 5 |
Coca-Cola
KO
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$438M |
| 4 |
Apple
AAPL
|
+$417M |
| 5 |
Aon
AON
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.4% |
| 2 | Healthcare | 20.27% |
| 3 | Consumer Staples | 11.15% |
| 4 | Consumer Discretionary | 9.81% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Aquestive Therapeutics
AQST
$481M
| $827K | ﹤0.01% |
189,669
-55,779
| -23% | -$219K |
|
2652
Soluna Holdings
SLNH
$188M
| $827K | ﹤0.01% |
+4,124
| New | +$828K |
|
2653
Origin Bancorp
OBK
$1.68B
| $826K | ﹤0.01% |
19,500
-5,100
| -21% | -$209K |
|
2654
Aligos Therapeutics
ALGS
$30.4M
| $825K | ﹤0.01% |
+2,128
| New | +$842K |
|
2655
Chord Energy
CHRD
$7.39B
| $825K | ﹤0.01% |
8,300
-5,700
| -41% | -$524K |
|
|
SSY
2656
DELISTED
SunLink Health Systems
SSY
| $825K | ﹤0.01% |
317,484
+5,100
| +2% | +$13.1K |
|
|
CALA
2657
DELISTED
Calithera Biosciences, Inc
CALA
| $825K | ﹤0.01% |
18,930
-17,324
| -48% | -$747K |
|
2658
VOC Energy
VOC
$51.5M
| $823K | ﹤0.01% |
179,207
+23,207
| +15% | +$102K |
|
|
VIVS
2659
VivoSim Labs
VIVS
$1.23M
| $822K | ﹤0.01% |
10,074
-2,767
| -22% | -$252K |
|
|
ERUS
2660
DELISTED
iShares MSCI Russia ETF
ERUS
| $821K | ﹤0.01% |
+17,200
| New | +$774K |
|
2661
Oak Valley Bancorp
OVLY
$284M
| $820K | ﹤0.01% |
46,767
-13,306
| -22% | -$235K |
|
2662
iShares Core S&P 500 ETF
IVV
$899B
| $819K | ﹤0.01% |
+1,900
| New | +$842K |
|
|
BLPH
2663
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $819K | ﹤0.01% |
201,706
-55,366
| -22% | -$231K |
|
2664
Fidelity MSCI Financials Index ETF
FNCL
$2.41B
| $816K | ﹤0.01% |
15,200
+8,500
| +127% | +$454K |
|
2665
OptimumBank Holdings
OPHC
$111M
| $816K | ﹤0.01% |
157,500
+11,101
| +8% | +$57.8K |
|
2666
Recon Technology
RCON
$3.82M
| $811K | ﹤0.01% |
+15,928
| New | +$922K |
|
|
HALL
2667
DELISTED
Hallmark Financial Services, Inc.
HALL
| $810K | ﹤0.01% |
22,194
-13,836
| -38% | -$587K |
|
2668
Citizens Community Bancorp
CZWI
$211M
| $802K | ﹤0.01% |
58,300
+18,900
| +48% | +$260K |
|
2669
Protara Therapeutics
TARA
$227M
| $802K | ﹤0.01% |
115,900
+64,473
| +125% | +$503K |
|
2670
Spyre Therapeutics
SYRE
$9.24B
| $797K | ﹤0.01% |
4,012
+1,981
| +98% | +$346K |
|
|
VBNK
2671
VersaBank
VBNK
$621M
| $797K | ﹤0.01% |
+72,300
| New | +$795K |
|
2672
Patria Investments
PAX
$1.83B
| $795K | ﹤0.01% |
48,700
+37,100
| +320% | +$603K |
|
2673
AXT Inc
AXTI
$4.92B
| $793K | ﹤0.01% |
+95,200
| New | +$887K |
|
2674
Atea Pharmaceuticals
AVIR
$386M
| $792K | ﹤0.01% |
+22,600
| New | +$627K |
|
2675
Fiverr
FVRR
$333M
| $786K | ﹤0.01% |
4,300
-90,900
| -95% | -$18.3M |
|
Similar funds
Renaissance Technologies's Q3 2021 Portfolio in Review
As of Q3 2021, Renaissance Technologies held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.
- Renaissance Technologies's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
- Renaissance Technologies added most to Nike in Q3 2021, an estimated $453M increase.
- Renaissance Technologies's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
- Renaissance Technologies fully exited Amazon in Q3 2021, selling an estimated $897M.
- Renaissance Technologies's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
- Renaissance Technologies opened 663 new positions and closed 653 in Q3 2021.
- Renaissance Technologies's portfolio value fell 3.3% quarter-over-quarter to $77.4B.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.